Continuing tirzepatide helped adults without diabetes maintain far more of their initial weight loss than stopping the drug, with the strongest effect seen in those who stayed on their maximum tolerated dose, according to results from the SURMOUNT-MAINTAIN trial
Medical Hypotheses, 77 (2), 220222
For the oral form, Rybelsus , the initial dose is set at 3 mg daily
Tirzepatide acts on both the GIP and GLP-1 receptors, while semaglutide acts on GLP-1 alone
Stay Hydrated Hydration is vital for the skin and contributes to maintaining glutathione results
A recent placebo-controlled, double-blind randomized trial in which daily oral doses of dietary sulforaphane over 18 weeks demonstrated substantial improvements in markers of autism spectrum disorder further highlights the possible impact on conditions other than cancer 13